Search Results - "SASADEUSZ, J"

HCV reinfection incidence among individuals treated for recent infection by Martinello, M., Grebely, J., Petoumenos, K., Gane, E., Hellard, M., Shaw, D., Sasadeusz, J., Applegate, T. L., Dore, G. J., Matthews, G. V.

“…Summary One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this analysis was to calculate the incidence of HCV…”
Get full text

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient by Macesic, N., Langsford, D., Nicholls, K., Hughes, P., Gottlieb, D. J., Clancy, L., Blyth, E., Micklethwaite, K., Withers, B., Majumdar, S., Fleming, S., Sasadeusz, J.

“…Cytomegalovirus (CMV) is a significant cause of morbidity, mortality and graft loss in solid organ transplantation (SOT). Treatment options for…”
Get full text

Characteristics and Treatment Outcomes among HIV-Infected Individuals in the Australian Trial in Acute Hepatitis C by Matthews, G. V., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., Lloyd, A., Kaldor, J., Dore, G. J.

“…Background. The Australian Trial in Acute Hepatitis C (ATAHC) is a National Institutes of Health-funded prospective cohort study of the natural history and…”
Get full text

Outcomes of Antiviral Retreatment for Immunocompromised Hosts With Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Positivity: A Multicenter Australian Retrospective Case Series by Bond, K A, Dendle, C, Guy, S, Slavin, M A, Smibert, O, Ibrahim, N, Kinsella, P M, Morrissey, C O, Moso, M A, Sasadeusz, J J

“…Abstract Outcomes are presented for a multisite retrospective case series, describing a contemporary cohort of 22 immunocompromised patients with persistent…”
Get full text

Immune Reconstitution Hepatitis in HIV and Hepatitis B Coinfection, Despite Lamivudine Therapy as Part of HAART by Drake, Anne, Mijch, Anne, Sasadeusz, Joe

“…Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection occurs commonly. The introduction of antiretroviral therapy can result in immune…”
Get full text

Regional challenges: evaluation of a hepatitis outreach programme using transient elastography (FibroScan) in Victoria by Thurnheer, M. C., Schulz, T. R., Nguyen, T., MacLachlan, J., Sasadeusz, J.

“…Background Evaluation of an outreach programme using a mobile transient elastography (TE) device (FibroScan) to improve liver disease assessment in different…”
Get full text

Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation by Sasadeusz, J., Prince, H.M., Schwarer, A., Szer, J., Stork, A., Bock, H.L., Povey, M., Nicholson, O., Innis, B.L.

“…Background Immunogenicity and safety of varicella vaccine (Varilrix™ [Oka‐RIT]; GlaxoSmithKline Vaccines) in adults who had undergone autologous hematopoietic…”
Get full text

Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfection by Doyle, J.S, Bowring, A.L, Iser, D.M, Sasadeusz, J, Roney, J, O’Reilly, M, Fairley, C, Gane, E, Hoy, J, Matthews, G.V, Medland, N, Moore, R, Prins, M, Stoové, M, Ban-Kiem, T, Hellard, M.E

Get full text

High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment by Bowing, A.L, Doyle, J.S, Iser, D.M, Sasadeusz, J, Roney, J, O’Reilly, M, Fairley, C, Gane, E, Hoy, J, Matthews, G.V, Medland, N, Moore, R, Prins, M, Stoové, M, Ban-Kiem, T, Hellard, M.E

Get full text

Safety and efficacy of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection genotype 1–6 and chronic kidney disease: an integrated analysis by Pol, S, Pockros, P, Pugatch, D, Brau, N, Landis, C, Elkhashab, M, Sasadeusz, J, Tran, A, Hu, Y, Kosloski, M, Mensa, F

Get full text

Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men by Mahony, Andrew A, Donnan, Ellen J, Lester, Rosemary A, Doyle, Joseph S, Knox, James, Tracy, Samantha L, Bowden, Scott, Sasadeusz, Joseph J

“…Objectives: To examine increased notifications of hepatitis C virus (HCV) in men who have sex with men (MSM) infected with HIV in Victoria, and evaluate HCV…”
Get full text

42 PREDICTING POST PARTUM HEPATITIS B VIRUS FLARES USING INNATE IMMUNE BIOMARKERS by Visvanathan, K, Skinner, N.A, Lewin, S, Giles, M, Sasadeusz, J

Get full text

Efficacy and safety of Glecaprevir/Pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 Study by Rockstroh, J, Lacombe, K, Viani, R.M, Orkin, C, Wyles, D, Luetkemeyer, A, Soto-Malave, R, Flisiak, R, Bhagani, S, Sherman, K.E, Shimonova, T, Ruane, P, Sasadeusz, J, Slim, J, Zhang, Z, Ng, T.I, Trinh, R, Sulkowski, M

Get full text

Hepatitis C treatment outcomes in Australian clinics by Gidding, Heather F, Law, Matthew G, Amin, Janaki, Ostapowicz, George, Weltman, Martin, Macdonald, Graeme A, Sasadeusz, Joe J, Haber, Paul AW, George, Jacob, Dore, Gregory J

“…Objective: To determine hepatitis C (HCV) treatment effectiveness and predictors of response in the “real‐world” Australian clinic setting. Design, setting and…”
Get full text

Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir +/− ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis –Final results of the REV1TAL study by Lubel, J.S, Pianko, S, Thompson, A, Strasser, S, Dore, G, Stuart, K, MacQuillan, G, Iser, D, Mitchell, J, Gazzola, A, Chivers, S, Mishra, G, Gow, P, George, J, Gough, J, Tse, E, Zekry, A, Levy, M, Fragomeli, V, Morales, B, Sasadeusz, J, Nazareth, S, Bollipo, S, Jones, T, Wade, A, Cheng, W, Wigg, A, Roberts, S

Get full text

P65 Nurse-led hepatitis C treatment models in drug and alcohol services can support, treatment uptake, healthcare engagement and community prescribing by S. Watkinson, S. Mujumdar, B. Monheit, J. Sasadeusz

Get full text

P745 SEQUENCING OF INITIAL AND RECURRENT HCV INFECTIONS IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN (MSM) by Macartney, M, Ricciardi, A, Rodger, A, Webster, D, Karageorgopoulos, D, Fernandez, T, Ferro, F, Sasadeusz, J, Bhagani, S

Get full text

P0847 : Malachite-II: Phase 3b trial of ombitasvir/paritaprevir/r and dasabuvir + ribavirin or telaprevir + peginterferon/ribavirin in peginterferon/ribavirin treatment-experienced adults with HCV genotype 1 by Dore, G, Knysz, B, Luo, Y, Janczewska, E, Streinu-Cercel, A, Caruntu, F.A, Motoc, A, Mazur, W, Shaw, D, Tornai, I, Sasadeusz, J, Skoien, R, Sullivan, D, Liu, X, Podsadecki, T

Get full text

371 THE IMPACT OF PREGNANCY ON VIROLOGICAL AND BIOCHEMICAL MARKERS OF HEPATITIS B INFECTION AND POST PARTUM HEPATITIS FLARES by Giles, M, Visvanathan, K, Sasadeusz, J

Get full text

1179 HIGH RATES OF SEXUALLY TRANSMITTED HCV RE-INFECTION IN HIV POSITIVE MEN WHO HAVE SEX WITH MEN: PREVENTION IS THE KEY by Sasadeusz, J, Rodger, A, Fernandez, T, Bhagani, S

Get full text